• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

窒息严重程度是接受低温治疗的新生儿中苯巴比妥清除率的一个协变量。

Severity of asphyxia is a covariate of phenobarbital clearance in newborns undergoing hypothermia.

作者信息

Pokorná Pavla, Posch Lenka, Šíma Martin, Klement Petr, Slanar Ondrej, van den Anker John, Tibboel Dick, Allegaert Karel

机构信息

a Department of Pediatrics, First Faculty of Medicine , Charles University in Prague and General University Hospital , Prague , Czech Republic.

b Institute of Pharmacology, First Faculty of Medicine , Charles University in Prague and General University Hospital in Prague , Prague , Czech Republic.

出版信息

J Matern Fetal Neonatal Med. 2019 Jul;32(14):2302-2309. doi: 10.1080/14767058.2018.1432039. Epub 2018 Feb 5.

DOI:10.1080/14767058.2018.1432039
PMID:29357720
Abstract

AIM

Phenobarbital (PB) pharmacokinetics (PK) in asphyxiated newborns show large variability, not only explained by hypothermia (HT). We evaluated potential relevant covariates of PK of PB in newborns treated with or without HT for hypoxic-ischemic encephalopathy (HIE).

METHODS

Clearance (CL), distribution volume (Vd) and elimination half-life (t) were calculated using one-compartment analysis. Covariates were clinical characteristics (weight, gestational age, hepatic, renal, and circulatory status), comedication and HIE severity [time to reach normal aEEG pattern (TaEEG), dichotomous, within 24 h] and asphyxia severity [severe aspyhxia = pH ≤7.1 + Apgar score ≤5 (5 min), dichotomous]. Student's t-test, two-way ANOVA, correlation and Pearson's chi-square test were used.

RESULTS

Forty newborns were included [14 non-HT; 26 HT with TaEEG <24 h in 14/26 (group) and TaEEG ≥24 h in 12/26 (group)]. Severe asphyxia was present in 26/40 [5/14 non-HT, 11/14 and 10/12 in both HT groups]. PB-CL, Vd and t were similar between the non-HT and HT group. However, within the HT group, PB-CL was significantly different between group and group (p = .043). ANOVA showed that HT (p = .034) and severity of asphyxia (p = .038) reduced PB-CL (-50%).

CONCLUSION

The interaction of severity of asphyxia and HT is associated with a clinical relevant reduced PB-CL, suggesting the potential relevance of disease characteristics beyond HT itself.

摘要

目的

窒息新生儿中苯巴比妥(PB)的药代动力学(PK)表现出很大的变异性,低温(HT)并非其唯一原因。我们评估了接受或未接受HT治疗的缺氧缺血性脑病(HIE)新生儿中PB PK的潜在相关协变量。

方法

采用单室分析法计算清除率(CL)、分布容积(Vd)和消除半衰期(t)。协变量包括临床特征(体重、胎龄、肝脏、肾脏和循环状态)、合并用药以及HIE严重程度[达到正常aEEG模式的时间(TaEEG),二分法,24小时内]和窒息严重程度[重度窒息=pH≤7.1+阿氏评分≤5(5分钟),二分法]。使用学生t检验、双向方差分析、相关性分析和Pearson卡方检验。

结果

纳入40例新生儿[14例未接受HT;26例接受HT,其中14/26例(组)TaEEG<24小时,12/26例(组)TaEEG≥24小时]。40例中有26例存在重度窒息[14例未接受HT的新生儿中有5例,接受HT的两组中分别有11/14例和10/12例]。未接受HT组和接受HT组之间的PB-CL、Vd和t相似。然而,在接受HT的组内,组与组之间的PB-CL存在显著差异(p=0.043)。方差分析显示,HT(p=0.034)和窒息严重程度(p=0.038)使PB-CL降低了50%。

结论

窒息严重程度与HT的相互作用与临床相关的PB-CL降低有关,提示除HT本身外,疾病特征可能具有潜在相关性。

相似文献

1
Severity of asphyxia is a covariate of phenobarbital clearance in newborns undergoing hypothermia.窒息严重程度是接受低温治疗的新生儿中苯巴比妥清除率的一个协变量。
J Matern Fetal Neonatal Med. 2019 Jul;32(14):2302-2309. doi: 10.1080/14767058.2018.1432039. Epub 2018 Feb 5.
2
Severity parameters for asphyxia or hypoxic-ischemic encephalopathy do not explain inter-individual variability in the pharmacokinetics of phenobarbital in newborns treated with therapeutic hypothermia.窒息或缺氧缺血性脑病的严重程度参数并不能解释接受治疗性低温治疗的新生儿中苯巴比妥药代动力学的个体间差异。
Minerva Pediatr (Torino). 2022 Apr;74(2):107-115. doi: 10.23736/S2724-5276.20.05740-0. Epub 2020 Oct 27.
3
Phenobarbital for neonatal seizures in hypoxic ischemic encephalopathy: a pharmacokinetic study during whole body hypothermia.苯巴比妥治疗缺氧缺血性脑病新生儿惊厥:全身低温期间的药代动力学研究。
Epilepsia. 2011 Apr;52(4):794-801. doi: 10.1111/j.1528-1167.2011.02978.x. Epub 2011 Mar 3.
4
Phenobarbital, Midazolam Pharmacokinetics, Effectiveness, and Drug-Drug Interaction in Asphyxiated Neonates Undergoing Therapeutic Hypothermia.苯巴比妥、咪达唑仑在亚低温治疗窒息新生儿中的药代动力学、疗效和药物相互作用。
Neonatology. 2019;116(2):154-162. doi: 10.1159/000499330. Epub 2019 Jun 28.
5
Does phenobarbital improve the effectiveness of therapeutic hypothermia in infants with hypoxic-ischemic encephalopathy?苯巴比妥是否能提高缺氧缺血性脑病婴儿亚低温治疗的疗效?
J Perinatol. 2012 Jan;32(1):15-20. doi: 10.1038/jp.2011.41. Epub 2011 Apr 28.
6
Pharmacokinetics and clinical efficacy of phenobarbital in asphyxiated newborns treated with hypothermia: a thermopharmacological approach.亚低温治疗窒息新生儿的苯巴比妥药代动力学和临床疗效:一种热药理学方法。
Clin Pharmacokinet. 2012 Oct 1;51(10):671-9. doi: 10.1007/s40262-012-0004-y.
7
Predictive Value of Thompson-Score for Long-Term Neurological and Cognitive Outcome in Term Newborns with Perinatal Asphyxia and Hypoxic-Ischemic Encephalopathy Undergoing Controlled Hypothermia Treatment.汤普森评分对接受亚低温治疗的足月围产期窒息和缺氧缺血性脑病新生儿长期神经和认知结局的预测价值。
Neonatology. 2018;114(4):341-347. doi: 10.1159/000490721. Epub 2018 Aug 21.
8
Drug Disposition in Neonatal Göttingen Minipigs: Exploring Effects of Perinatal Asphyxia and Therapeutic Hypothermia.新生儿哥廷根迷你猪的药物处置:探索围产期窒息和治疗性低温的影响。
Drug Metab Dispos. 2024 Jul 16;52(8):824-835. doi: 10.1124/dmd.124.001677.
9
Electroencephalography and brain magnetic resonance imaging in asphyxia comparing cooled and non-cooled infants.窒息婴儿的脑电图和脑磁共振成像比较,冷却与非冷却婴儿。
Eur J Paediatr Neurol. 2019 Jan;23(1):181-190. doi: 10.1016/j.ejpn.2018.09.001. Epub 2018 Sep 12.
10
Elevated S100B urine levels predict seizures in infants complicated by perinatal asphyxia and undergoing therapeutic hypothermia.尿 S100B 水平升高可预测围产期窒息并接受治疗性低温治疗的婴儿发生癫痫。
Clin Chem Lab Med. 2024 Jan 30;62(6):1109-1117. doi: 10.1515/cclm-2023-1471. Print 2024 May 27.

引用本文的文献

1
Predicting Volume of Distribution in Neonates: Performance of Physiologically Based Pharmacokinetic Modelling.预测新生儿的分布容积:基于生理学的药代动力学建模的性能
Pharmaceutics. 2023 Sep 19;15(9):2348. doi: 10.3390/pharmaceutics15092348.
2
What is the Best Predictor of Phenobarbital Pharmacokinetics to Use for Initial Dosing in Neonates?用于新生儿初始给药的苯巴比妥药代动力学的最佳预测指标是什么?
Pharmaceutics. 2021 Feb 25;13(3):301. doi: 10.3390/pharmaceutics13030301.
3
Pharmacokinetics during therapeutic hypothermia for neonatal hypoxic ischaemic encephalopathy: a literature review.
新生儿缺氧缺血性脑病治疗性低温期间的药代动力学:文献综述
BMJ Paediatr Open. 2020 Jun 15;4(1):e000685. doi: 10.1136/bmjpo-2020-000685. eCollection 2020.
4
A Physiology-Based Pharmacokinetic Framework to Support Drug Development and Dose Precision During Therapeutic Hypothermia in Neonates.一个基于生理学的药代动力学框架,以支持新生儿治疗性低温期间的药物开发和剂量精准度。
Front Pharmacol. 2020 May 13;11:587. doi: 10.3389/fphar.2020.00587. eCollection 2020.
5
Drug Disposition and Pharmacotherapy in Neonatal ECMO: From Fragmented Data to Integrated Knowledge.新生儿体外膜肺氧合中的药物处置与药物治疗:从零散数据到综合知识
Front Pediatr. 2019 Sep 3;7:360. doi: 10.3389/fped.2019.00360. eCollection 2019.